Ferndale Laboratories is dedicated to discovering, developing and delivering unique, branded pharmaceuticals that provide therapeutic dermatology solutions to the under-served medical specialties. More
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
The Pierre Fabre Group, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004. More
SkinMedica's Mission is to build a specialty skin care pharmaceutical company by developing, acquiring and commercializing patented cosmeceutical and pharmaceutical products. More
CollaGenex is developing dermatological applications of its proprietary IMPACS technology. Oracea (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More